Proteoglycan Protocols [Methods in Molec io 171] - R. Iozzo (Humana) WW.pdf

(3169 KB) Pobierz
Methods in Molecular Biology TM
Methods in Molecular Biology TM
VOLUME 171
Proteoglycan
Protocols
Proteoglycan
Protocols
Edited by
Renato V. Iozzo, MD
Edited by
Renato V. Iozzo, MD
HUMANA PRESS
HUMANA PRESS
764784223.004.png 764784223.005.png 764784223.006.png
Isolation from Cell Cultures and Tissues
3
1
Isolation of Proteoglycans from Cell Cultures and Tissues
Masaki Yanagishita
1. Introduction
Proteoglycans are a class of glycosylated proteins characterized by the presence of
glycosaminoglycans as a carbohydrate component, which endow them with unique
biological as well as biochemical properties. Therefore, isolation of proteoglycans
from various biological sources such as cell cultures and tissues could be achieved by
ordinary molecular purification procedures utilizing their general molecular proper-
ties and by those taking advantages of the presence of glycosaminoglycan moiety.
This chapter focuses on the latter experimental procedures, which are particularly use-
ful for obtaining total proteoglycan and glycosaminoglycan species from various
biological sources. These protocols could be followed by purification procedures
specific to individual proteoglycan species (i.e., by using antibodies to core proteins,
or binding proteins to specific sequences of glycosaminoglycans) to select specific
molecules.
Two major classes of well-established purification procedures aiming at the pres-
ence of glycosaminoglycans in the molecule have been used extensively. They
include (1) density gradient ultracentrifugation, and (2) anion-exchange chroma-
tography. The former procedure makes use of the fact that the glycosaminoglycan
moiety of proteoglycans has high specific gravity, so, proteoglycans with a large
number of glycosaminoglycans have high molecular densities (often as high as
those of nucleic acids). Therefore, such a procedure is particularly suited for the
purification of proteoglycans with many glycosaminoglycan chains (e.g., aggrecan,
the major proteoglycan in cartilage tissues). On the other hand, the procedure is not
suitable for isolating proteoglycans with only few glycosaminoglycans and high
protein contents (e.g., “small, leucine-rich proteoglycans” and cell surface heparan
sulfate proteoglycans). Purification procedures belonging to the latter class take
advantage of high negative charges contributed by sulfate groups and carboxyl
groups universally present in glycosaminoglycans. Thus, they can be widely used
From: Methods in Molecular Biology, Vol. 171: Proteoglycan Protocols
Edited by: R. V. Iozzo © Humana Press Inc., Totowa, NJ
3
764784223.007.png
4
Yanagishita
Fig. 1. A flow diagram of proteoglycan isolation from a radiolabeled cell culture.
for isolating any species of proteoglycans and glycosaminoglycans, and are the main
subject of following discussion.
This chapter outlines a proteoglycan-isolating protocol from a metabolically radiola-
beled cell culture ( see Fig. 1 ) as an example case, which addresses technical problems
often encountered when working with small quantities of proteoglycans. Other reviews
on similar subjects can be consulted for more detailed discussions (1–3) .
2. Materials
2.1. Extraction
1. Buffer: 4 M guanidine HCl, 0.05 M Na acetate, pH 6.0, containing 2% (w/v) Triton X-100
and protease inhibitors (1 m M phenylmethylsulfonyl fluoride, 10 m M N-ethylmaleimide,
10 m M disodium ethylenediaminetetraacetic acid (4) .
2. Stock solutions (100 × concentrated) of phenylmethylsulfonyl fluoride and N-ethylmaleimide
are prepared in ethanol and added to the guanidine HCl buffer just prior to use (they are
unstable in aqueous solutions).
2.2. Solvent Exchange
1.
Sephadex G-50, fine (Amersham Pharmacia Biotech). Preswelling of Sephadex can be
done in hot water (off the heater), which achieves sterilization, degassing, and shortening of
swelling time. Extreme caution should be exercised when adding Sephadex powder to
764784223.001.png
Isolation from Cell Cultures and Tissues
5
boiling water, to avoid flushing. A convenient concentration of gel (50% slurry) can be
made by mixing 5 g of Sephadex G-50 with 100 mL of water. Bacteriostatic agents (e.g.,
0.02% Na azide) should be added for long-term storage.
2. 10 mL plastic disposable pipet (Falcon).
3. Glass wool, #3950 (Corning).
4. Buffer: 8 M urea, 0.20 M NaCl, 0.05 M Na acetate, 0.5% Triton X-100, pH 6.0.
2.3. Anion-Exchange Chromatography
1. Q-Sepharose, fast flow (Amersham Pharmacia Biotech). Q-Sepharose has to be
preequilibrated with the low salt buffer as described below.
2. Low salt buffer: 8 M urea, 0.20 M NaCl, 0.05 M Na acetate, 0.5% Triton X-100, pH 6.0.
3. High salt buffer: 8 M urea, 1.5 M NaCl, 0.05 M Na acetate, 0.5% Triton X-100, pH 6.0.
4. Gradient former (a simple configuration can be made with two beakers).
5. Peristaltic pump.
2.4. Gel Filtration Chromatography
1. Superose 6, HR 10/30 (Amersham Pharmacia Biotech).
2. Buffer: 4 M guanidine HCl, 0.05 M Na acetate, 0.5% (w/v) Triton X-100, pH 6.0.
3. Methods
General experimental procedures introducing radioactive precursors into
proteoglycans using cell cultures and tissue cultures are reviewed elsewhere (1) .
3.1. Extraction
1. After removing media from the cell layer, approximately 2 mL of extraction buffer (per
35-mm-diameter cell culture dish) is added to a culture plate ( see Note 1 ).
2. Proteoglycans are extracted within 2–3 h of constant shaking at 4°C.
3. Passing the extract through a 1-mL pipet tip up and down approximately 10 times reduces
the viscosity of the solution caused by DNA.
4. Extraction of proteoglycans from tissues: As used originally in the extraction of
proteoglycan from cartilage tissue (3) , 4 M guanidine generally provides excellent solu-
bilization of proteoglycans.
5. When tissues are to be extracted, ordinarily approximately 10 times volume of 4 M guanidine
HCl buffer successfully solubilizes proteoglycans from finely minced tissues in 12 h at 4°C.
6. Additional consideration should be made when extraction of cell-associated proteoglycans
is attempted; i.e., inclusion of sufficient amounts of detergent may be necessary (such as 2%
Triton X-100) for the solubilization of proteoglycans (5) .
7. Secreted proteoglycans in cell culture media are generally already soluble, but, in order to
minimize interactions between highly charged proteoglycans and other molecules, direct
addition of solid guanidine HCl (0.53 g of solid guanidine HCl per milliliter of media makes
4 M guanidine HCl solution) is frequently used.
3.2. Solvent Exchange
1.
In order to prepare the extracted proteoglycans in 4 M guanidine HCl for the anion-
exchange chromatography procedure in the next step, guanidine HCl has to be replaced
with a solvent compatible with the procedure.
2.
A preferred solvent is a urea buffer, since it disrupts molecular interactions by interfering
with the formation of hydrogen bonds.
3.
A convenient buffer-exchange procedure can be done by gel filtration (such as Sephadex
G-50 chromatography) using a small disposable pipet. This process is also very conve-
764784223.002.png
6
Yanagishita
nient to remove unincorporated radioactive precursors, when radiolabeled cell cultures
were extracted with a 4 M guanidine HCl solvent.
4. Preparation of Sephadex G-50 column: Pour preswollen Sephadex G-50 (50% slurry) into
a 10-mL plastic disposable column (which has been cut at the top with a file and plugged
with glass wool at the bottom) to make 8 mL bed volume.
5. Remove excess water and equilibrate the column with 8 M urea buffer (a total of 9 mL is
sufficient to equilibrate the column).
6. Carefully prepare a flat gel surface with a glass Pasteur pipet and remove excess urea buffer.
Apply a 2-mL sample and discard the eluent.
7. After the entire sample is in the column, carefully overlay 3 mL of buffer and collect
eluent until the entire buffer is in the column (3-mL fraction collected). This fraction
contains proteoglycans and other macromolecules in 8 M urea buffer, while leaving
small molecules in the original sample (guanidine HCl, isotope precursors, etc.) behind
in the column.
8. At this point, the column can be safely disposed of as a radioactive waste.
3.3. Anion-Exchange Chromatography
3.3.1. Preparation of Q-Sepharose Column (see Note 2 )
and Sample Application
1. 2 mL of preequilibrated Q-Sepharose (1 mL of Q-Sepharose can bind up to 3–5 mg of
proteoglycans) is packed into a small column (10-mL plastic pipet cut by a file and plugged
with glass wool at the bottom).
2. Alternatively, 2 mL of Q-Sepharose is mixed with the sample in 8 M urea buffer and
gently shaken for 1 h, then packed into the column; this latter method gives uniform
binding of proteoglycans to Q-Sepharose, resulting in a better flow property, especially
when a large quantity of materials is used.
3. After sample application, the column is washed with 10 mL of the low-salt buffer.
4. Then the column is connected to a gradient former and eluted with a total of approximately
40 mL of buffer with a flow rate of 10–15 mL/h.
5. Every 1- to 2-mL fraction is collected and monitored for NaCl concentration by conductivity
measurement ( see Fig. 2 ). Eluent fractions are monitored for proteoglycans (by radioac-
tivity detection or colorimetric procedures; a convenient and sensitive colorimetric pro-
cedure using Safranin O is described in ref. 6 ).
6. Typically, heparan sulfate proteoglycans are eluted in a peak at approximately 0.5 M
NaCl and chondroitin sulfate proteoglycans at 0.65 M NaCl.
3.4. Gel Filtration Chromatography
1.
Proteoglycans with differing molecular weights purified by Q-Sepharose chromatogra-
phy are further separated by gel filtration chromatography. Superose 6 (or equivalent gel)
is suitable for resolving small proteoglycans (“small, leucine-rich proteoglycans”, cell
surface heparan sulfate proteoglycans, etc.) from large proteoglycans (e.g., aggrecan,
versican, and perlecan) and partially degraded proteoglycans.
2.
Superose 6 is equilibrated in 4 M guanidine HCl buffer containing 0.5% Triton X-100
( see note 2 ), and up to 0.5 mL of sample can be loaded to the column.
3.
The column is eluted at a flow rate of 0.4 mL/min and each 1-min fraction is collected
( see Fig. 3 ).
4.
Eluent fractions are analyzed for proteoglycan content (by radioactivity detection or colo-
rimetric procedures).
764784223.003.png
Zgłoś jeśli naruszono regulamin